Patent details

Basic Information

Publication number:

EP3383385

PCT Application Number:

EP2016079511

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP168057925

PCT Publication Number:

WO2017093443

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MELFLUFEN DOSAGE REGIMENS FOR CANCER

French Title of Invention:

RÉGIMES POSOLOGIQUES DE MELFLUFEN POUR LE CANCER

German Title of Invention:

MELFLUFENDOSIERUNGSPLÄNE FÜR KREBS

SPC Number:

Dates

Filing date:

01/12/2016

Grant date:

29/07/2020

EP Publication Date:

10/10/2018

PCT Publication Date:

08/06/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/07/2020

EP B1 Publication Date:

29/07/2020

EP B2 Publication Date:

06/09/2023

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/12/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/05/2024

 

 

Name:

ONCOPEPTIDES INNOVATION AB

Address:

Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)

History of Owners

From:

30/08/2023

To:

27/05/2024

Name:

Oncopeptides AB

Address:

Västra Trädgårdsgatan 15, 111 53 Stockholm, Sweden (SE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/09/2020

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

LINDBERG, Jakob

Address:

Sweden (SE)

Priority

Priority Number:

201521217

Priority Date:

01/12/2015

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 31/223; A61K 31/573;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2024/07

Publication date:

03/06/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202031

Publication date:

29/07/2020

Description:

Grant (B1)

2

Issue number:

202122

Publication date:

02/06/2021

Description:

Opposition procedure started

3

Issue number:

202336

Publication date:

06/09/2023

Description:

Patent maintained (B2 publication)

4

Issue number:

202035

Publication date:

26/08/2020

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20240000244A

Date Registered:

27/05/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

ONCOPEPTIDES INNOVATION AB

Address:

Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

13/11/2024

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
27/05/2024	Request For Change	17
31/05/2024	Outgoing Correspondence	1
23/09/2020	Outgoing Correspondence	1
23/09/2020	Power Of Attorney	1